Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.

OBJECTIVE: To examine whether the demonstrated efficacy of tissue-type plasminogen activator (t-PA) for acute ischemic stroke can be effective in a community setting. METHODS: Sixty-eight consecutive patients with acute ischemic stroke treated with IV t-PA within 3 hours of symptom onset by attendin...

Full description

Bibliographic Details
Main Authors: Buchan, A, Barber, P, Newcommon, N, Karbalai, H, Demchuk, A, Hoyte, K, Klein, G, Feasby, T
Format: Journal article
Language:English
Published: 2000
_version_ 1826303832504664064
author Buchan, A
Barber, P
Newcommon, N
Karbalai, H
Demchuk, A
Hoyte, K
Klein, G
Feasby, T
author_facet Buchan, A
Barber, P
Newcommon, N
Karbalai, H
Demchuk, A
Hoyte, K
Klein, G
Feasby, T
author_sort Buchan, A
collection OXFORD
description OBJECTIVE: To examine whether the demonstrated efficacy of tissue-type plasminogen activator (t-PA) for acute ischemic stroke can be effective in a community setting. METHODS: Sixty-eight consecutive patients with acute ischemic stroke treated with IV t-PA within 3 hours of symptom onset by attending general neurologists in a busy teaching hospital. Outcome measures at 3 months were the National Institute of Health Stroke Scale (NIHSS), functional outcome (independence [modified Rankin score 0-2], dependence [modified Rankin score 3-5], and death), and symptomatic hemorrhage. Appropriately treated patients were defined by adherence to the National Institute of Neurological Disorders and Stroke (NINDS) guidelines. Effectiveness is expressed as the absolute risk reduction in which the baseline risk is assumed to be similar to that of the NINDS control group. RESULTS: Of 68 consecutively treated patients (with a mean baseline NIHSS score of 15 +/- 6), 26 (38%) made a full recovery and 39 (57%) made an independent recovery. The 11 patients who violated protocol had a lower probability of independence (p < 0.02) and full neurologic recovery (p < 0.02) and a higher probability of symptomatic hemorrhage (p < 0.05) and death (p < 0.01) compared with those of 57 patients treated according to NINDS guidelines. CONCLUSIONS: The use of t-PA for stroke in this community is effective with a number needed to treat of six. The risk of symptomatic hemorrhage is similar to that noted in randomized trials. Treating patients who violate protocol results in excess risk with no observable benefit.
first_indexed 2024-03-07T06:08:41Z
format Journal article
id oxford-uuid:eeb66e32-1aad-43b2-b845-17c2fe7d0f81
institution University of Oxford
language English
last_indexed 2024-03-07T06:08:41Z
publishDate 2000
record_format dspace
spelling oxford-uuid:eeb66e32-1aad-43b2-b845-17c2fe7d0f812022-03-27T11:34:55ZEffectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:eeb66e32-1aad-43b2-b845-17c2fe7d0f81EnglishSymplectic Elements at Oxford2000Buchan, ABarber, PNewcommon, NKarbalai, HDemchuk, AHoyte, KKlein, GFeasby, TOBJECTIVE: To examine whether the demonstrated efficacy of tissue-type plasminogen activator (t-PA) for acute ischemic stroke can be effective in a community setting. METHODS: Sixty-eight consecutive patients with acute ischemic stroke treated with IV t-PA within 3 hours of symptom onset by attending general neurologists in a busy teaching hospital. Outcome measures at 3 months were the National Institute of Health Stroke Scale (NIHSS), functional outcome (independence [modified Rankin score 0-2], dependence [modified Rankin score 3-5], and death), and symptomatic hemorrhage. Appropriately treated patients were defined by adherence to the National Institute of Neurological Disorders and Stroke (NINDS) guidelines. Effectiveness is expressed as the absolute risk reduction in which the baseline risk is assumed to be similar to that of the NINDS control group. RESULTS: Of 68 consecutively treated patients (with a mean baseline NIHSS score of 15 +/- 6), 26 (38%) made a full recovery and 39 (57%) made an independent recovery. The 11 patients who violated protocol had a lower probability of independence (p < 0.02) and full neurologic recovery (p < 0.02) and a higher probability of symptomatic hemorrhage (p < 0.05) and death (p < 0.01) compared with those of 57 patients treated according to NINDS guidelines. CONCLUSIONS: The use of t-PA for stroke in this community is effective with a number needed to treat of six. The risk of symptomatic hemorrhage is similar to that noted in randomized trials. Treating patients who violate protocol results in excess risk with no observable benefit.
spellingShingle Buchan, A
Barber, P
Newcommon, N
Karbalai, H
Demchuk, A
Hoyte, K
Klein, G
Feasby, T
Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
title Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
title_full Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
title_fullStr Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
title_full_unstemmed Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
title_short Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
title_sort effectiveness of t pa in acute ischemic stroke outcome relates to appropriateness
work_keys_str_mv AT buchana effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness
AT barberp effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness
AT newcommonn effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness
AT karbalaih effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness
AT demchuka effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness
AT hoytek effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness
AT kleing effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness
AT feasbyt effectivenessoftpainacuteischemicstrokeoutcomerelatestoappropriateness